Doximity Inc


Doximity Inc

Health CareHealth Care Providers
  • Price (USD)62.26
  • Today's Change0.35 / 0.57%
  • Shares traded1.41m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 08 2021 19:13 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Doximity, Inc. provides digital platform for United States (U.S) medical professionals. The Company’s cloud-based platform provides tools to its members, which helps them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the medical news and research, and manage careers. The Company support physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company’s platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enables pharmaceutical and health system customers to get content, services, and peer connections to the medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions include voice and video dialer that are designed to connect patients with care providers.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2010
  • Employees713.00
  • Location
    Doximity Inc500 THIRD STREETSAN FRANCISCO 94107United StatesUSA
  • Phone+1 (650) 549-4330
  • Fax+1 (302) 655-5049
  • Websitehttps://www.doximity.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Switch Inc558.41m22.09m6.36bn759.00152.4220.5529.7811.380.17230.17232.961.280.2292--23.08735,716.801.991.742.472.5843.4146.378.695.84--2.420.720869.9110.6513.9874.26-26.7112.87--
Change Healthcare Inc3.33bn-50.90m6.45bn15.00k--1.9910.951.93-0.1575-0.157510.3210.420.3325--4.18222,328.10-0.5075---0.5593--58.36---1.53----1.200.5897---6.44---1,897.69------
Zynga Inc2.72bn-89.87m7.06bn2.25k--2.3151.952.59-0.084-0.0842.472.730.4851--12.261,212,033.00-1.60-3.24-2.08-3.9863.0663.18-3.30-7.73--2.150.3067--49.4220.89-1,124.21--25.93--
Dun & Bradstreet Holdings Inc2.05bn-53.80m8.38bn4.04k--2.3415.404.09-0.1067-0.1055.518.310.2163--7.60506,907.70-0.5356---0.5927--69.27---2.48----1.080.4949--9.14--68.86------
Tusimple Holdings Inc-100.00bn-100.00bn8.52bn1.00k--6.04----------6.62----------------------------0.0033--159.58---37.08------
Concentrix Corp5.42bn342.10m9.32bn270.00k27.053.5614.851.726.586.58104.3649.961.07--5.1720,078.766.83--10.53--35.21--6.38----19.980.2523--0.2469--40.67------
GDS Holdings Ltd - ADR1.14bn-197.53m9.57bn1.48k--2.4752.698.39-1.10-1.106.3721.660.1344--4.22771,429.00-2.13-2.04-2.50-2.4123.7125.38-15.83-14.00--0.3680.5324--39.2152.16-47.49--62.16--
Tencent Music Entertainment Group - ADR5.02bn579.67m11.46bn4.77k19.701.46--2.280.34360.34362.984.640.4901848.5813.191,053,165.005.90--6.93--30.99--12.04--2.62--0.0972--14.62--4.34------
Doximity Inc-100.00bn-100.00bn11.61bn713.00--14.98----------4.13----------------------------0.00--77.76--99.06------
Leidos Holdings Inc13.50bn776.00m12.61bn39.00k16.613.0611.540.93395.415.4194.0629.391.0641.086.49346,102.606.105.378.327.0614.7913.565.784.670.98637.190.550438.8710.8421.15-5.8520.9146.631.22
LYFT Inc2.81bn-1.21bn14.11bn4.68k--9.51--5.02-3.71-3.718.534.360.5736----600,699.40-24.69---45.22--32.93---43.05-----34.350.3338---34.60--32.64------
Goodrx Holdings Inc685.71m-283.61m15.95bn----18.84--23.26-0.7178-0.71781.652.120.4338--8.46---17.94---18.73--93.88---41.36-----12.080.4396--41.85---544.56------
Data as of Dec 08 2021. Currency figures normalised to Doximity Inc's reporting currency: US Dollar USD

Institutional shareholders

34.80%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 20215.16m8.37%
The Vanguard Group, Inc.as of 30 Sep 20214.17m6.76%
Whale Rock Capital Management LLCas of 30 Sep 20213.93m6.38%
Fidelity Management & Research Co. LLCas of 30 Sep 20212.04m3.31%
Credit Suisse Securities (USA) LLC (Broker)as of 30 Sep 20211.27m2.05%
Credit Suisse Asset Management (Schweiz) AGas of 29 Oct 20211.25m2.03%
Morgan Stanley & Co. LLCas of 30 Sep 20211.01m1.64%
Morgan Stanley Investment Management, Inc.as of 30 Sep 2021986.24k1.60%
Echo Street Capital Management LLCas of 30 Sep 2021879.95k1.43%
BlackRock Fund Advisorsas of 30 Sep 2021763.10k1.24%
More ▼
Data from 30 Sep 2021 - 30 Nov 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.